SCHEMBL852665

SCHEMBL852665

C#CC(OCC)(OCC)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL29104373 0.85 ALOX15 (0.37)
SCHEMBL30609843 0.77
SCHEMBL28361427 0.73
SCHEMBL30831243 0.73 ADRB2 (0.36)
SCHEMBL7519689 0.71
SCHEMBL26113252 0.71
SCHEMBL4366627 0.69
SCHEMBL10826404 0.67
SCHEMBL6537226 0.67
Urea SCHEMBL29104384 0.66 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250009915-A1 NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF FUJIFILM CORPORATION (JP) 2025-01-09 US disclosed
US-20240409575-A1 METHODS OF PREPARING 1'-CYANO NUCLEOSIDES GILEAD SCIENCES, INC. 2024-12-12 US disclosed
CN-118679426-A Resin composition, cured product, laminate, method for producing cured product, method for producing laminate, method for producing semiconductor device, and semiconductor device 富士胶片株式会社 2024-09-20 CN disclosed
US-12012431-B2 Methods of preparing 1′-cyano nucleosides GILEAD SCIENCES, INC. (US) 2024-06-18 US disclosed
CN-117940516-A Resin composition, cured product, laminate, method for producing cured product, method for producing laminate, method for producing semiconductor device, and semiconductor device 富士胶片株式会社 2024-04-26 CN disclosed
CN-117881745-A Resin composition, cured product, laminate, method for producing cured product, method for producing laminate, method for producing semiconductor device, and compound 富士胶片株式会社 2024-04-12 CN disclosed
CN-117836715-A Resin composition, cured product, laminate, method for producing cured product, method for producing laminate, method for producing semiconductor device, and alkali generator 富士胶片株式会社 2024-04-05 CN disclosed
CN-117295794-A Resin composition, cured product, laminate, method for producing cured product, semiconductor device, and compound 富士胶片株式会社 2023-12-26 CN disclosed
CN-117120550-A Resin composition, cured product, laminate, method for producing cured product, and semiconductor device 富士胶片株式会社 2023-11-24 CN disclosed
CN-117120512-A Resin composition, cured product, laminate, method for producing cured product, semiconductor device, and polyimide precursor 富士胶片株式会社 2023-11-24 CN disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
EP-1390362-A1 SUBSTITUTED BENZOFURANS AND BENZOTHIOPHENES, METHODS OF MAKING AND METHODS OF USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-02-25 EP disclosed
US-20030018064-A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-01-23 US disclosed
US-6486320-B2 CONVERGENT SYNTHESIS STARTING FROM A 3-(AMINOMETHYL)QUINOLINE DERIVATIVE AND 5-HYDROXY-5-ETHYL-6-OXO-5,6-DIHYDROPYRANCARBOXYLIC ACID AND THE INTERMEDIATES OBTAINED. AVENTIS PHARMA S.A. (FR) 2002-11-26 US disclosed
US-20020169200-A1 Substituted indoles and their use as integrin antagonists 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-11-14 US disclosed
WO-2002088118-A1 SUBSTITUTED BENZOFURANS AND BENZOTHIOPHENES, METHODS OF MAKING AND METHODS OF USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-11-07 WO disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed
US-20020045756-A1 Preparation of camptothecin and of its derivatives AVENTIS PHARMA S.A. 2002-04-18 US disclosed
WO-2002022618-A1 METHOD FOR PREPARING CAMPTOTHECIN AND ITS DERIVATIVES AVENTIS PHARMA S.A. (FR) 2002-03-21 WO disclosed
US-5306598-A High contrast, for graphic arts INTERNATIONAL PAPER COMPANY (US) 1994-04-26 US disclosed